Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
repetitive transcranial magnetic stimulation (rTMS)
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine Addiction
1 trial -
rhBMP-2 placement
ADIAL PHARMACEUTICALS, INC.
Tooth Loss
1 trial -
salbutamol
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial -
salvianolate injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Angina, Stable
1 trial -
sapropterin dihydrochloride
BioMarin Pharmaceutical Australia Pty Ltd
Autism Spectrum Disorder
1 trial -
sequential combined AVS
Yang Xiaotian
Primary Aldosteronism
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
sodium bicarbonate Ringer's solution
The First People's Hospital of Lianyungang
Hepatic Ischemia
1 trial -
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
substructure informed planning
United Therapeutics Europe Ltd
Brain Tumor
1 trial -
sunitinib or pazopanib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metastatic Renal Cell Carcinoma
1 trial -
telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP)
Praxis Precision Medicines
Telemedicine
1 trial -
tested formula with fiber
United Therapeutics Europe Ltd
Atopic Dermatitis
1 trial -
the absorbable hemostat and suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ovarian Cyst Benign
1 trial -
the traditional Chinese medicine prescription ' Shenzhuo Decoction '
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Kidney Disease (DKD)
1 trial -
the usage of Olverembatinib combined with Inotuzumab Ozogamicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ph+ ALL
1 trial -
therapeutic progesterone
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
tiered/titrated vitamin D dosing
BRIGHT MINDS BIOSCIENCES INC.
HIV-associated Co-morbidities
1 trial -
trans-resveratrol
Hong Kong Baptist University
Eye Disease
1 trial -
transdermal nicotine patches
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use
1 trial -
treatment with or without colistin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carbapenem-Resistant Enterobacteriaceae Infection
1 trial -
warfarin
Hospital Authority, Hong Kong
Deep Venous Thromboembolism
1 trial -
zanubrutinib 160 mg BID orally
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma
1 trial -
zanubrutinib, bendamustine, and obinutuzumab
The First People's Hospital of Lianyungang
Follicular Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources